IgG Glycosylation: Biomarker, Functional Modulator, and Structural Component
The Journal of Immunology · 01.12.2024 · 213 (11) · 1573-1584
DOI: 10.4049/jimmunol.2400447 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Immunology, online erschienen am 01.12.2024. Verfasst von Barbara Radovani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biotechnology and Drug Development, University of Rijeka, Rijeka, Croatia. Hauptthemen laut MEDLINE: Immunoglobulin G, Biomarkers. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 180 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft (DFG), Croatian Science Foundation.
Abstract (Originalsprache)
The family of IgG Abs is a crucial component of adaptive immunity. Glycosylation of IgG maintains its structural integrity and modulates its effector functions. In this review, we discuss IgG glycosylation covering cell biological as well as therapeutic and disease-related aspects, focusing on the glycan structures in distinct IgG regions (Fab versus Fc). We also cover the impact of IgG glycosylation on disease modulation and therapeutic outcomes, alongside the potential for development of vaccines designed to induce Ag-specific IgG with glycoforms for optimal immune responses. Overall, we emphasize the significance of studying glycosylation to enhance our understanding of the dynamics and functional impacts of IgG glycosylation. These insights could be beneficial for advancing future research and clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Biotechnology and Drug Development, University of Rijeka, Rijeka, Croatia.
- Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
- Profile Center Immunomedicine, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
ORCID-Profile: Barbara Radovani
Förderung
- Deutsche Forschungsgemeinschaft (DFG)
- Croatian Science Foundation
Zitieren
APA
Radovani, B., & Nimmerjahn, F. (2024). IgG Glycosylation: Biomarker, Functional Modulator, and Structural Component. The Journal of Immunology, 213(11), 1573-1584. https://doi.org/10.4049/jimmunol.2400447
Vancouver
Radovani B, Nimmerjahn F. IgG Glycosylation: Biomarker, Functional Modulator, and Structural Component. The Journal of Immunology. 2024;213(11):1573-1584. doi:10.4049/jimmunol.2400447
BibTeX
@article{Radovani2024,
author = {Radovani, Barbara and Nimmerjahn, Falk},
title = {IgG Glycosylation: Biomarker, Functional Modulator, and Structural Component},
journal = {The Journal of Immunology},
year = {2024},
volume = {213},
number = {11},
pages = {1573--1584},
doi = {10.4049/jimmunol.2400447}
}
EUVIMED